14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ARCT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for Arcturus Therapeutics Holdings Inc. as stock downgraded to Strong Sell Candidate.
(Updated on Apr 15, 2024)

Sell candidate since Apr 12, 2024 Loss -3.68% PDF

The Arcturus Therapeutics Holdings Inc. stock price fell by -3.68% on the last day (Monday, 15th Apr 2024) from $30.43 to $29.31. During the last trading day the stock fluctuated 5.36% from a day low at $29.12 to a day high of $30.68. The price has been going up and down for this period, and there has been a -11.4% loss for the last 2 weeks. Volume has increased on the last day by 99 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 499 thousand shares were bought and sold for approximately $14.62 million.

Given the current short-term trend, the stock is expected to fall -5.85% during the next 3 months and, with a 90% probability hold a price between $27.59 and $39.18 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

ARCT Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Arcturus Therapeutics Holdings Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $31.24 and $34.99. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -31.82%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Arcturus Therapeutics Holdings Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.56 between high and low, or 5.36%. For the last week, the stock has had daily average volatility of 5.40%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ARCT) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect Arcturus Therapeutics Holdings Inc. to open at $29.70, and during the day (based on 14 day Average True Range), to move between $27.36 and $31.26, which gives a possible trading interval of +/-$1.95 (+/-6.66%) up or down from last closing price. If Arcturus Therapeutics Holdings Inc. takes out the full calculated possible swing range there will be an estimated 13.33% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $32.86, some $3.55 (12.11%) from the current price of $29.31, our system finds the risk reward not very attractive.

Is Arcturus Therapeutics Holdings Inc. stock A Buy?

Arcturus Therapeutics Holdings Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.027 Strong Sell Candidate Downgraded

Predicted Opening Price for Arcturus Therapeutics Holdings Inc. of Tuesday, April 16, 2024

Fair opening price April 16, 2024 Current price
$29.70 ( 1.34%) $29.31

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ARCT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 31.26 6.66 %
R2 30.67 4.63 %
R1 30.30 3.38 %
Current price: 29.31
Support S1 29.11 -0.691 %
S2 28.74 -1.95 %
S3 28.14 -3.98 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 34.79 18.70 %
R2 33.13 13.03 %
R1 32.86 12.11 %
Current price 29.31
Support S1 0 .
S2 0 .
S3 0 .

ARCT Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 27, 2012 Jan 08, 2013 Jan 15, 2013 $0.0596 0%
2 Dec 28, 2012 Jan 04, 2013 Jan 15, 2013 $0.0596 0%
3 Nov 28, 2012 Dec 05, 2012 Dec 15, 2012 $0.0600 0%
4 Oct 26, 2012 Nov 06, 2012 Nov 15, 2012 $0.0600 0%
5 Sep 27, 2012 Oct 03, 2012 Oct 15, 2012 $0.0600 0%

FAQ

What is the symbol for Arcturus Therapeutics Holdings Inc. Stock and on which exchange is it traded?
The symbol for Arcturus Therapeutics Holdings Inc. is ARCT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Arcturus Therapeutics Holdings Inc. Stock?
Arcturus Therapeutics Holdings Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Arcturus Therapeutics Holdings Inc. Stock?
Arcturus Therapeutics Holdings Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Arcturus Therapeutics Holdings Inc. Stock.

What's the current price of Arcturus Therapeutics Holdings Inc. Stock?
As of the end of day on the 2024-04-15, the price of an Arcturus Therapeutics Holdings Inc. (ARCT) share was $29.31.

What is the 52-week high and low for Arcturus Therapeutics Holdings Inc. Stock?
The 52-week high for Arcturus Therapeutics Holdings Inc. Stock is $43.74 and the 52-week low is $17.52.

What is the market capitalization of Arcturus Therapeutics Holdings Inc. Stock?
As of the 2024-04-15, the market capitalization of Arcturus Therapeutics Holdings Inc. is 788.885M.

When is the next earnings date for Arcturus Therapeutics Holdings Inc.?
The upcoming earnings date for Arcturus Therapeutics Holdings Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings. Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as we... ARCT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT